Home | Welcome to Contract Pharma   
Last Updated Tuesday, October 21 2014
Print

Financial Report: AbbVie



Published April 26, 2013
AbbVie
 
1Q Revenues: $4.3 billion (+4%)
 
1Q Earnings: $968 million (+10%)
 
Comments: Growth was driven by Humira sales in the U.S. and internationally, up 16% to $2.2 billion. Synagis sales were $345 million, down 1%. AndroGel sales were up 3% to $240 million. TriCor/Trilipix sales were down 50% to $128 million due to the loss of exclusivity. Lupron sales were down 9% to $181 million.


blog comments powered by Disqus
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On